Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Rudolph

Showing results (331-340 of 349) with videos related to

Pageof 35
Sort By:
Cancer Research|July 1, 1988
A phase I study of recombinant interleukin 2 plus recombinant beta-interferonR L Krigel, K A Padavic-Shaller, A R Rudolph, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1992
Lung injury after deposition of IgA immune complexes. Requirements for CD18 and L-arginineM S Mulligan, J S Warren, C W Smith, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1988
Specificity of tumor necrosis factor toxicity for human mammary carcinomas relative to normal mammary epithelium and correlation with response to doxorubicinC Dollbaum, A A Creasey, S H Dairkee, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|March 23, 2005
Steady-state pharmacokinetics of bupropion SR in juvenile patientsW Burleson Daviss, James M Perel, George R Rudolph, et al.
Therapeutic Drug Monitoring|April 22, 2006
Acute antidepressant response and plasma levels of bupropion and metabolites in a pediatric-aged sample: an exploratory studyW Burleson Daviss, James M Perel, David A Brent, et al.
American Journal of Human Genetics|June 12, 1999
A gene for inherited cutaneous venous anomalies ("glomangiomas") localizes to chromosome 1p21-22L M Boon, P Brouillard, A Irrthum, et al.
Protein Engineering|January 1, 1992
Biochemical properties of the kringle 2 and protease domains are maintained in the refolded t-PA deletion variant BM 06.022U Kohnert, R Rudolph, J H Verheijen, et al.
Psychopharmacology Bulletin|January 1, 1996
Venlafaxine for panic disorder: results from a double-blind, placebo-controlled studyM H Pollack, J J Worthington, M W Otto, et al.
Structure (London, England : 1993)|November 15, 1996
Enzyme flexibility, solvent and 'weak' interactions characterize thrombin-ligand interactions: implications for drug designR A Engh, H Brandstetter, G Sucher, et al.
Transplantation Proceedings|April 1, 1996
Continuous complement (C) inhibition using soluble C receptor type 1 (sCR1): effect on hyperacute rejection (HAR) of pig-to-primate cardiac xenograftsS k Pruitt, R R Bollinger, B H Collins, et al.
Pageof 35

Showing results (331-340 of 349) with videos related to

Sort By:
Pageof 35
Cancer Research|July 1, 1988
A phase I study of recombinant interleukin 2 plus recombinant beta-interferonR L Krigel, K A Padavic-Shaller, A R Rudolph, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1992
Lung injury after deposition of IgA immune complexes. Requirements for CD18 and L-arginineM S Mulligan, J S Warren, C W Smith, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1988
Specificity of tumor necrosis factor toxicity for human mammary carcinomas relative to normal mammary epithelium and correlation with response to doxorubicinC Dollbaum, A A Creasey, S H Dairkee, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|March 23, 2005
Steady-state pharmacokinetics of bupropion SR in juvenile patientsW Burleson Daviss, James M Perel, George R Rudolph, et al.
Therapeutic Drug Monitoring|April 22, 2006
Acute antidepressant response and plasma levels of bupropion and metabolites in a pediatric-aged sample: an exploratory studyW Burleson Daviss, James M Perel, David A Brent, et al.
American Journal of Human Genetics|June 12, 1999
A gene for inherited cutaneous venous anomalies ("glomangiomas") localizes to chromosome 1p21-22L M Boon, P Brouillard, A Irrthum, et al.
Protein Engineering|January 1, 1992
Biochemical properties of the kringle 2 and protease domains are maintained in the refolded t-PA deletion variant BM 06.022U Kohnert, R Rudolph, J H Verheijen, et al.
Psychopharmacology Bulletin|January 1, 1996
Venlafaxine for panic disorder: results from a double-blind, placebo-controlled studyM H Pollack, J J Worthington, M W Otto, et al.
Structure (London, England : 1993)|November 15, 1996
Enzyme flexibility, solvent and 'weak' interactions characterize thrombin-ligand interactions: implications for drug designR A Engh, H Brandstetter, G Sucher, et al.
Transplantation Proceedings|April 1, 1996
Continuous complement (C) inhibition using soluble C receptor type 1 (sCR1): effect on hyperacute rejection (HAR) of pig-to-primate cardiac xenograftsS k Pruitt, R R Bollinger, B H Collins, et al.
Pageof 35